PASD1 and acute myeloid leukemia: Of note was the predominance of PASD1-specific T-cell responses in 8 of 26 AML patients, perhaps reflecting the presence of four HLA-A2 restricted pMHC-PASD1 on the array, rather than the single pMHC-epitopes detecting most other tumour antigens.